Segment Reporting - Summary of Financial Information with Respect to Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Segment revenues:
Total segment revenues	$ 38,469		$ 29,784		$ 87,132	$ 61,911
Segment gross profit:
Total segment gross profit	17,134		11,980		45,117	28,144
Unallocated:
Research and development	(31,123)		(21,092)		(58,945)	(42,540)
Sales and marketing	(7,428)		(5,380)		(14,099)	(10,619)
General and administrative	(22,056)		(15,850)		(44,189)	(29,239)
Gain (loss) on equity investments	11,828				11,828	(1,781)
Change in fair value	(15,700)		(4,918)		(21,864)	19,906
Other (expense) income	(296)		357		32	777
Income tax expense	(33)		(67)		(5)	(141)
Net loss	(47,674)	$ (34,451)	(34,970)	$ (523)	(82,125)	(35,493)
Operating Segments | Software Segment
Segment revenues:
Total segment revenues	30,011		24,052		63,092	50,392
Segment gross profit:
Total segment gross profit	22,910		18,411		48,480	38,845
Operating Segments | Drug Discovery Segment
Segment revenues:
Total segment revenues	8,458		5,732		24,040	11,519
Segment gross profit:
Total segment gross profit	$ (5,776)		$ (6,431)		$ (3,363)	$ (10,701)